PHASIUM / Megmeet USA Revenue and Competitors

Location

N/A

Total Funding

Electronics

Industry

Estimated Revenue & Valuation

  • PHASIUM / Megmeet USA's estimated annual revenue is currently $23.3M per year.(i)
  • PHASIUM / Megmeet USA's estimated revenue per employee is $245,000

Employee Data

  • PHASIUM / Megmeet USA has 95 Employees.(i)
  • PHASIUM / Megmeet USA grew their employee count by 20% last year.

PHASIUM / Megmeet USA's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M5-88%N/AN/A
#2
$23.3M9520%N/AN/A
#3
$38.8M1447%N/AN/A
#4
$7.6M39-11%N/AN/A
#5
$2.5M1713%N/AN/A
#6
$8.2M422%N/AN/A
#7
$6.1M313%N/AN/A
#8
$3.3M7-42%$19.8MN/A
#9
$120.1M3923%N/AN/A
#10
$4.3M25-4%N/AN/A
Add Company

What Is PHASIUM / Megmeet USA?

We are an ISO 13485 certified manufacturer specializing in developing cost effective, high performance power solutions for complex medical device applications such as respirators, concentrators, CPAPs, patient monitors, infusion pumps, home medical equipment and cart based devices. Phasium works with the world’s leading silicon companies to supply high-efficiency, highly-reliable, smart, green medical power products. Our designs emphasize state-of-the-art power conversion techniques, superior thermal management and include substantial design margin and high-quality passive components from top-tier suppliers. Our competitively-priced product offering includes standard internal and external AC/DC and DC/DC power supplies, custom power supplies, battery chargers, docking stations and battery packs. As the premier brand of medical-grade power products for Megmeet Electronics, all products are manufactured in a dedicated medical site at Megmeet’s ISO13485 registered 13-acre manufacturing and design campus.

keywords:N/A

N/A

Total Funding

95

Number of Employees

$23.3M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.3M957%N/A
#2
$23M95-2%N/A
#3
$23.3M95-2%N/A
#4
$26.1M95-10%$186.1M
#5
$38M9522%$176M